Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder
Status:
Completed
Trial end date:
2001-10-01
Target enrollment:
Participant gender:
Summary
Our study aims at contributing to a valid appraisal of the magnitude of naltrexone efficacy
as an antidissociative agent by using a double-blind randomized controlled trial.